Skip to main content
Clinical Trials/CTRI/2024/05/067125
CTRI/2024/05/067125Not yet recruitingPhase 2

A Comparative Study Between Levobupivacaine and Ropivacaine for Epidural labour Analgesia

JNMC1 site in 1 country100 target enrollmentStarted: May 19, 2024Last updated:

Trial Snapshot

Phase
Phase 2
Status
Not yet recruiting
Sponsor
Enrollment
100
Locations
1
Primary Endpoint
In Epidural labor Analgesia, levobupivacaine has demonstrated superior efficacy compared to ropivacaine.

Study Overview

Brief Summary

WhileRopivacaine Initiates Analgesia More Quickly, Levobupivacaine Provides ALonger-Lasting Effect. Both Drugs Are Safe and Result In Comparable MaternalAnd Fetal Outcomes. It’s Important To Consider These Factors Along With IndividualPatient Circumstances When Choosing An Anaesthetic For Epidural LaborAnalgesia.

Study Design

Study Type
Interventional
Allocation
Random Number Table
Masking
Not Applicable

Eligibility Criteria

Ages
18.00 Year(s) to 32.00 Year(s) (—)
Sex
Female

Inclusion Criteria

  • Asa Grade 1 & 2 Primigravidae With Singleton Uncomplicated Pregnancy Asa Grade 1 & 2 All Patients Willing To Give Informed Written Consent.

Exclusion Criteria

  • Asa Class 3 Or Higher High Risk Complicated Pregnancy Contraindication Of Neuraxial Block Patient With Bleeding Disorder Patients With Psychiatric Illness.

Outcomes

Primary Outcomes

In Epidural labor Analgesia, levobupivacaine has demonstrated superior efficacy compared to ropivacaine.

Time Frame: 2 YEARS

Secondary Outcomes

  • APPRAISE HAEMODYNAMIC DURING LABOUR(ASSESS THE MATERNAL AND FOETAL OUTCOME)

Investigators

Sponsor
JNMC
Sponsor Class
Private medical college

Study Sites (1)

Loading locations...

Similar Trials